Cancer News - Topix
A new peptide developed by researchers in Temple University's College of Science and Technology has demonstrated efficacy against triple negative breast cancer .
Sent with Reeder
Sent from my iPad
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment